JP2025084968A5 - - Google Patents

Info

Publication number
JP2025084968A5
JP2025084968A5 JP2025034187A JP2025034187A JP2025084968A5 JP 2025084968 A5 JP2025084968 A5 JP 2025084968A5 JP 2025034187 A JP2025034187 A JP 2025034187A JP 2025034187 A JP2025034187 A JP 2025034187A JP 2025084968 A5 JP2025084968 A5 JP 2025084968A5
Authority
JP
Japan
Prior art keywords
lipid
solution
mrna
lipids
pharmaceutical formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025034187A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025084968A (ja
Filing date
Publication date
Priority claimed from JP2021568011A external-priority patent/JP7707080B2/ja
Application filed filed Critical
Publication of JP2025084968A publication Critical patent/JP2025084968A/ja
Publication of JP2025084968A5 publication Critical patent/JP2025084968A5/ja
Pending legal-status Critical Current

Links

JP2025034187A 2019-05-14 2025-03-05 Mrna担持脂質ナノ粒子を調製する改善されたプロセス Pending JP2025084968A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962847837P 2019-05-14 2019-05-14
US62/847,837 2019-05-14
JP2021568011A JP7707080B2 (ja) 2019-05-14 2020-05-14 Mrna担持脂質ナノ粒子を調製する改善されたプロセス
PCT/US2020/032943 WO2020232276A1 (en) 2019-05-14 2020-05-14 Improved process of preparing mrna-loaded lipid nanoparticles

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021568011A Division JP7707080B2 (ja) 2019-05-14 2020-05-14 Mrna担持脂質ナノ粒子を調製する改善されたプロセス

Publications (2)

Publication Number Publication Date
JP2025084968A JP2025084968A (ja) 2025-06-03
JP2025084968A5 true JP2025084968A5 (cg-RX-API-DMAC7.html) 2025-11-06

Family

ID=70919274

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021568011A Active JP7707080B2 (ja) 2019-05-14 2020-05-14 Mrna担持脂質ナノ粒子を調製する改善されたプロセス
JP2025034187A Pending JP2025084968A (ja) 2019-05-14 2025-03-05 Mrna担持脂質ナノ粒子を調製する改善されたプロセス

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021568011A Active JP7707080B2 (ja) 2019-05-14 2020-05-14 Mrna担持脂質ナノ粒子を調製する改善されたプロセス

Country Status (12)

Country Link
US (1) US20220218612A1 (cg-RX-API-DMAC7.html)
EP (1) EP3968952A1 (cg-RX-API-DMAC7.html)
JP (2) JP7707080B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220024022A (cg-RX-API-DMAC7.html)
CN (1) CN114126588A (cg-RX-API-DMAC7.html)
AU (2) AU2020274758B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021022909A2 (cg-RX-API-DMAC7.html)
CA (1) CA3140423A1 (cg-RX-API-DMAC7.html)
IL (1) IL288020A (cg-RX-API-DMAC7.html)
MX (1) MX2021013959A (cg-RX-API-DMAC7.html)
SG (1) SG11202112574RA (cg-RX-API-DMAC7.html)
WO (1) WO2020232276A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA49421A (fr) 2017-06-15 2020-04-22 Modernatx Inc Formulations d'arn
MX2020002348A (es) 2017-08-31 2020-10-08 Modernatx Inc Métodos de elaboración de nanopartículas lipídicas.
US12090235B2 (en) 2018-09-20 2024-09-17 Modernatx, Inc. Preparation of lipid nanoparticles and methods of administration thereof
DK3864163T3 (da) 2018-10-09 2024-05-06 Univ British Columbia Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
CN113939282A (zh) 2019-01-31 2022-01-14 摩登纳特斯有限公司 制备脂质纳米颗粒的方法
US12678406B2 (en) 2020-10-12 2026-07-14 Translate Bio Inc. Process of preparing ice-based lipid nanoparticles
CA3198411A1 (en) * 2020-10-12 2022-04-21 Translate Bio, Inc. Improved process of preparing mrna-loaded lipid nanoparticles
MX2023004371A (es) * 2020-10-14 2023-07-26 George Mason Res Foundation Inc Lípidos ionizables, y métodos de fabricación y uso de los mismos.
EP4763287A2 (en) 2021-09-03 2026-06-24 CureVac SE Novel lipid nanoparticles for delivery of nucleic acids
CN115745815B (zh) * 2021-09-03 2025-06-10 广州谷森制药有限公司 阳离子脂质化合物
EP4422698A1 (en) 2021-10-29 2024-09-04 CureVac SE Improved circular rna for expressing therapeutic proteins
KR102772764B1 (ko) * 2021-11-10 2025-02-27 주식회사 에스엠엘바이오팜 트레할로즈 유도체 및 신규 구조 유지 화합물을 포함하는 핵산 의약품 전달용 지질나노입자의 약학 조성물
WO2023092151A1 (en) * 2021-11-22 2023-05-25 Ohio State Innovation Foundation Compositions and methods for the treatment of neurodegenerative disorders
EP4469091A1 (en) 2022-01-28 2024-12-04 CureVac SE Nucleic acid encoded transcription factor inhibitors
CA3248209A1 (en) 2022-05-25 2023-11-30 CureVac SE Escherichia coli Antigenic Polypeptide-Based Nucleic Acid Vaccine (FIMH)
JP2023181989A (ja) * 2022-06-13 2023-12-25 上海臻上医薬科技有限公司 マイクロニードル注射製剤およびその使用
WO2024089638A1 (en) 2022-10-28 2024-05-02 Glaxosmithkline Biologicals Sa Nucleic acid based vaccine
KR20250153298A (ko) 2023-03-08 2025-10-24 큐어백 에스이 핵산 전달을 위한 신규의 지질 나노입자 제형
WO2024230934A1 (en) 2023-05-11 2024-11-14 CureVac SE Therapeutic nucleic acid for the treatment of ophthalmic diseases
WO2026033123A1 (en) 2024-08-08 2026-02-12 Sanofi Pasteur Inc. Lipid nanoparticle formulations for mrna delivery

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US5132418A (en) 1980-02-29 1992-07-21 University Patents, Inc. Process for preparing polynucleotides
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4401796A (en) 1981-04-30 1983-08-30 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5262530A (en) 1988-12-21 1993-11-16 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
FR2645866B1 (fr) 1989-04-17 1991-07-05 Centre Nat Rech Scient Nouvelles lipopolyamines, leur preparation et leur emploi
US5334761A (en) 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
US5700642A (en) 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
CA2569664C (en) 2004-06-07 2013-07-16 Protiva Biotherapeutics, Inc. Lipid encapsulated interfering rna
AU2009303345B2 (en) 2008-10-09 2015-08-20 Arbutus Biopharma Corporation Improved amino lipids and methods for the delivery of nucleic acids
WO2010053572A2 (en) 2008-11-07 2010-05-14 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
SI2506857T1 (en) 2009-12-01 2018-08-31 Translate Bio, Inc. Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases
EP4074693A1 (en) 2011-06-08 2022-10-19 Translate Bio, Inc. Cleavable lipids
KR20220025112A (ko) 2011-06-08 2022-03-03 샤이어 휴먼 지네틱 테라피즈 인크. Mrna 전달을 위한 지질 나노입자 조성물 및 방법
US9512073B2 (en) 2011-10-27 2016-12-06 Massachusetts Institute Of Technology Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
ES2967701T3 (es) * 2013-03-15 2024-05-03 Translate Bio Inc Mejora sinergística de la entrega de ácidos nucleicos mediante formulaciones mezcladas
WO2015184256A2 (en) 2014-05-30 2015-12-03 Shire Human Genetic Therapies, Inc. Biodegradable lipids for delivery of nucleic acids
WO2016004318A1 (en) * 2014-07-02 2016-01-07 Shire Human Genetic Therapies, Inc. Encapsulation of messenger rna
WO2016118724A1 (en) 2015-01-21 2016-07-28 Moderna Therapeutics, Inc. Lipid nanoparticle compositions
EP3247398A4 (en) 2015-01-23 2018-09-26 Moderna Therapeutics, Inc. Lipid nanoparticle compositions
RS63051B1 (sr) 2015-12-22 2022-04-29 Modernatx Inc Jedinjenja i kompozicije za intracelularnu isporuku agenasa
EP3442590A2 (en) 2016-04-13 2019-02-20 Modernatx, Inc. Lipid compositions and their uses for intratumoral polynucleotide delivery
AU2017283479B2 (en) 2016-06-13 2023-08-17 Translate Bio, Inc. Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiency
US20180153822A1 (en) * 2016-11-10 2018-06-07 Translate Bio, Inc. Process of Preparing mRNA-Loaded Lipid Nanoparticles
CA3077391A1 (en) * 2017-09-29 2019-04-04 Intellia Therapeutics, Inc. In vitro method of mrna delivery using lipid nanoparticles
CN118436618A (zh) * 2018-05-30 2024-08-06 川斯勒佰尔公司 信使rna疫苗及其用途
US20220016265A1 (en) * 2018-11-09 2022-01-20 Translate Bio, Inc. Messenger rna therapy for treatment of ocular diseases

Similar Documents

Publication Publication Date Title
JP2022532213A5 (cg-RX-API-DMAC7.html)
US12102720B2 (en) Cleavable lipids
US20220411791A1 (en) Nuclease Resistant Polynucleotides and Uses Thereof
JP7707080B2 (ja) Mrna担持脂質ナノ粒子を調製する改善されたプロセス
EP4467653B1 (en) Improved mrna-loaded lipid nanoparticles and processes of making the same
JP2022542562A (ja) mRNA担持脂質ナノ粒子の安定性組成物および作製のプロセス
JP2024513048A5 (cg-RX-API-DMAC7.html)
JP7744354B2 (ja) Mrna担持脂質ナノ粒子を調製する改善された方法
IL307319A (en) Compositions and methods for delivery of rna
US20180153822A1 (en) Process of Preparing mRNA-Loaded Lipid Nanoparticles
US20160287725A1 (en) Liver specific delivery of messenger rna
US12564645B2 (en) Methods for treatment of methylmalonic acidemia
JP2019533707A5 (cg-RX-API-DMAC7.html)
US20200215157A1 (en) Composition and methods for treatment of primary ciliary dyskinesia
RU2021136653A (ru) УЛУЧШЕННЫЙ СПОСОБ ПОЛУЧЕНИЯ ЛИПИДНЫХ НАНОЧАСТИЦ, ЗАГРУЖЕННЫХ мРНК
HK40097156A (en) Cleavable lipids
HK40082296A (en) Cleavable lipids